CD146 immunohistochemical staining for the separation of benign from malignant mesothelial proliferations
Sign Up to like & getrecommendations! Published in 2021 at "Virchows Archiv"
DOI: 10.1007/s00428-021-03077-7
Abstract: The separation of benign from malignant mesothelial cells is often a challenging problem. Some studies have suggested that immunohistochemical staining of CD146 can be used to make this distinction, but there are marked differences in… read more here.
Keywords: immunohistochemical staining; mesotheliomas; malignant mesothelial; separation benign ... See more keywords
c-MET Immunohistochemistry For Differentiating Malignant Mesothelioma from Benign Mesothelial Proliferations.
Sign Up to like & getrecommendations! Published in 2020 at "Human pathology"
DOI: 10.1016/j.humpath.2020.08.010
Abstract: The separation of benign from malignant mesothelial proliferations can be a difficult problem for the surgical pathologist. c-MET is a receptor tyrosine kinase that is overexpressed and detectable by immunohistochemistry in many malignancies, including malignant… read more here.
Keywords: immunohistochemistry; mesothelial proliferations; score; benign mesothelial ... See more keywords
Usefulness of Cyclin D1/Podoplanin Dual Immunohistochemical Stain to Differentiate Malignant Mesothelioma From Reactive Mesothelial Proliferations.
Sign Up to like & getrecommendations! Published in 2022 at "American journal of clinical pathology"
DOI: 10.1093/ajcp/aqac022
Abstract: OBJECTIVES To examine the potential of cyclin D1/podoplanin dual immunohistochemical stain to differentiate malignant mesothelioma from reactive mesothelial proliferations. METHODS Cyclin D1/podoplanin dual immunohistochemistry was performed on 34 surgical cases of reactive mesothelial proliferations, malignant… read more here.
Keywords: mesothelial proliferations; cyclin podoplanin; malignant mesothelioma; podoplanin dual ... See more keywords